Diagnostic testing

Syndromic testing with QIAstat-Dx

To support the efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN has developed the QIAstat-Dx Respiratory SARS-CoV-2 Panel. This version of our multiplex syndromic cartridge enables detection of the SARS-CoV-2 virus that causes COVID-19 in addition to 20+ other respiratory pathogens.*

High throughput, multiplex testing with NeuMoDx

The NeuMoDx 96 and NeuMoDx 288 systems offer rapid and fully automated PCR for the detection of SARS-CoV-2 along with influenza A/B and RSV. Within 80 minutes, your lab can get fast and accurate answers – supporting actionable clinical decisions.

Rapid high-throughput targeted testing with NeuMoDx

The NeuMoDx 96 and NeuMoDx 288 systems offer a rapid and fully automated PCR test for the detection of SARS-CoV-2 that can deliver a result in about an hour. NeuMoDx systems provide an ideal solution for hospitals or central testing labs, delivering the speed and flexibility to support the large numbers of patient samples they receive.

Increase lab throughput with our innovative liquid sample prep

The artus SARS-CoV-2 Prep&Amp UM Kit is an innovative liquid-based kit for SARS-CoV-2 detection. With fewer and simpler workflow steps, you can accelerate your lab's turnaround time while decreasing plastic usage, cost and hands-on time. With artus Prep&Amp, you integrate the sample preparation and the detection in a streamlined liquid workflow - getting quick results in 90 minutes.

A new tool in the fight against COVID-19

Cell mediated immunity is an enduring and reliable marker of the adaptive immune response after COVID-19 vaccination. T cell responses to SARS-CoV-2 decline more slowly than antibody responses and may provide a more sensitive way to monitor immune responses to SARS-CoV-2 vaccination than serological assays alone. QuantiFERON SARS-CoV-2 features trusted QuantiFERON technology to measure cell mediated immune response after SARS-CoV-2 vaccination.